Skip to content

Pharm'up development

Active Private limited companyfounded 2006active for 20 yearsRue du Viaduc 28, 7500 TournaiKBO/BCE: BE 0881.338.337

Annual accounts 2025

micro format, filed on 01-07-2026, 30 days before the deadline
€157,338
▲ 18.1%
€157,338
▲ 18.1%
-
-
53.5%
▲ 5.1 percentage points
2.15
▲ 0.21

Turnover and EBIT margin are not published. The micro format does not require them. The turnover shown is an estimate from the gross margin.

Turnover ≈ €780,000. Estimated: probably between €380,000 and €1.4m.

Money flows

no detail for 2025

Balance sheet

balance sheet total €286,691 on 31-12-2025
What the company ownsHow it is paid for

in euro

in euro

Position in the sector

53.5%

Higher than 60% of 13,800 companies in 2025.

2.15

Higher than 60% of 13,181 companies in 2025.

37.4%

Higher than 93% of 13,360 companies in 2025.

Pharm'up development Middle half of the sector 80% of the sector Micro accounts in wholesale trade (NACE 46)

Net result: top quarter · Equity: middle half · Balance sheet total: middle half · Working capital: top quarter

Filed annual accounts

as filed with the National Bank, click a year to choose it
Line Trend2025202420232022202120202019201820172016201520142013201220112010200920082007
Balance sheet: assets
20/58 286,691262,799290,913292,892246,093279,350169,042169,719153,836123,733131,549113,133195,959130,47272,162108,03094,32870,59529,164
21/28 ----------3,7247,44911,17314,898--12,56725,134-
21 ----------------12,56725,134-
22/27 ----------3,7247,44911,17314,898-----
24 ----------3,7247,44911,17314,898-----
29/58 286,691262,799290,913292,892246,093279,350169,042169,719153,836123,733127,825105,684184,786115,57472,162108,03081,76145,46129,164
3 28,93733,02126,54726,05037,61043,78243,78243,78259,04662,49849,7597,70250,3503,40315,31521,50713,51131,559-
30/36 28,93733,02126,54726,05037,61043,78243,78243,78259,04662,49849,7597,70250,3503,40315,31521,50713,51131,559-
40/41 94,81248,33389,36092,60283,115102,04395,25661,71447,88842,36936,18235,84829,65727,82641,34919,15019,55013,4171,048
40 94,81246,78183,83689,33281,573100,50263,59955,56938,88435,72327,78825,07724,89721,67628,14417,71919,5185,672-
41 -1,5525,5243,2701,5421,54231,6576,1459,0036,6468,39410,7714,7606,15013,2051,431337,7451,048
50/53 -120,000-----------------
54/58 162,94361,398174,892174,240125,368133,52429,41863,67046,90218,86641,88462,134104,77984,34615,01366,88748,107027,630
490/1 -47114---586553------486486593486486
Balance sheet: equity and liabilities
10/49 286,691262,799290,913292,892246,093279,350169,042169,719153,836123,733131,549113,133195,959130,47272,162108,03094,32870,59529,164
10/15 153,486127,266104,885154,729142,874149,178140,740137,226104,77387,27175,63025,30112,23012,57514,76516,47551,91027,90222,089
10/11 10,00010,00010,00010,00010,00010,00010,00010,00010,00010,00010,00010,00010,00010,00010,00010,00010,00010,00010,000
100 ------18,60018,60018,60018,60018,60018,60018,60018,60018,60018,60018,60018,60018,600
101 ------8,6008,6008,6008,6008,6008,6008,6008,6008,6008,6008,6008,6008,600
13 101,86052,86080,860130,860130,860130,86092,86064,86014,86014,86014,86014,8601,8601,8601,8601,86041,76017,76011,860
130/1 ---1,8601,8601,860-------------
130 ------1,8601,8601,8601,8601,8601,8601,8601,8601,8601,8601,8601,8601,860
1311 ---1,8601,8601,860-------------
133 101,86052,86080,860129,000129,000129,00091,00063,00013,00013,00013,00013,000----39,90015,90010,000
14 41,62664,40614,02513,8692,0148,31837,88062,36679,91362,41150,7704413707152,9054,615150142229
17/49 133,205135,533186,027138,163103,219130,17228,30132,49449,06236,46155,91987,832183,729117,89757,39891,55542,41942,6937,075
17 --------------2,95011,54619,76927,636-
170/4 --------------2,95011,54619,76927,636-
42/48 133,205135,533186,027138,163103,219130,17228,30132,49449,06236,46155,91987,832183,729117,89754,44780,00922,65015,0577,075
42 -------------2,9508,5958,2237,8687,527-
43 -----------------2,450-
430/8 -----------------2,450-
44 3,297399647-15,0868,6942,3061,3922,0723,87273744,49490,08139,7709692,0531,3921,89857
440/4 3,297399647-15,0868,6942,3061,3922,0723,87273744,49490,08139,7709692,0531,3921,89857
45 33,93013,75735,70426,48530,95651,3322956017,6907,46826,9893348,3988,35827526,98213,1522,9416,811
450/3 33,93013,75735,70426,48530,95651,3322956017,6907,46826,9893348,3988,35827526,98213,1522,9416,811
47/48 95,977121,377149,677111,67757,17770,14525,96630,54129,30025,12228,19443,00485,25166,81944,60842,751239239207
Income statement
70 -----------90,41394,58081,74078,60475,69278,719--
76A ---------224---------
9900 157,338133,213130,327165,64898,679144,86744,76085,85560,86954,45382,42627,03742,95545,52122834,98251,16222,76421,199
60/61 -----------63,37651,62560,10491,62640,71027,557--
630 ---------1,8823,7243,7243,7243,724-12,56712,56712,5671,150
640/8 ---1,542540----------3733481,074
9901 157,338133,213130,327164,10698,625144,86744,76085,85560,86952,57178,70223,31339,23141,79622822,41538,2239,85018,975
75/76B 5041,817----3----0-4164692722719
75 5041,817----3----0-4164692722719
65/66B 3833483703483463463537293371,2951,7991,4331,5232,0312,1021,3191,5751,33784
65 3833483703483463463537293371,2951,7991,4331,5232,0312,1021,3191,5751,33784
9903 157,458134,683129,957163,75898,279144,52244,40985,12660,53251,27676,90321,88037,70839,769-1,71121,16536,9208,78318,901
67/77 50,23734,30233,80141,90324,58242,08415,89530,17320,53017,13526,5738,80913,05412,959-6,60012,9132,9706,812
9904 107,220100,38196,156121,85573,696102,43828,51454,95240,00234,14150,32913,07124,65526,810-1,71114,56624,0075,81312,089
9905 107,220100,38196,156121,85573,696102,43828,51454,95240,00234,14150,32913,07124,65526,810-1,71114,56624,0075,81312,089
Appropriation of the result
9906 171,626114,406110,025123,86982,014140,31890,880134,866102,41384,91150,77013,44125,37029,7152,90514,71524,1506,04212,089
14P 64,40614,02513,8692,0148,318--------------
791/2 51,00028,00050,000--13,000---------39,900---
691/2 100,000----51,00028,00050,000---13,000----24,0005,90011,860
6920 ------------------1,860
6921 100,000----51,00028,00050,000---13,000----24,0005,90010,000
694/7 81,00078,000146,000110,00080,00094,00025,00022,50022,50022,500--25,00029,000-50,000---
694 81,00078,000146,000110,00080,00094,00025,00022,50022,50022,500--25,00029,000-50,000---
Document PDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDF

The notes to these accounts have 5 items, including the statement of assets and debts, the cost breakdown and rights and commitments. You find them in the accounts filed with the NBB.

Source: Annual accounts 2025 at the NBB, filed on 01-07-2026.

Download as CSV

Filings

each dot is a set of accounts, on the day it reached the National Bank
Financial year Type Filed Reference Document
31-12-2025 micro format 01-07-2026 2026-00237324 PDF
31-12-2024 micro format 01-07-2025 2025-00207595 PDF
31-12-2023 micro format 03-07-2024 2024-00205081 PDF
31-12-2022 micro format 05-07-2023 2023-00208227 PDF
31-12-2021 micro format 10-08-2022 2022-20286104 PDF
31-12-2020 micro format 29-06-2021 2021-28300169 PDF
31-12-2019 micro format 19-06-2020 2020-19200226 PDF
31-12-2018 micro format 01-08-2019 2019-43000354 PDF
31-12-2017 micro format 16-07-2018 2018-33700253 PDF
31-12-2016 micro format 16-08-2017 2017-44600334 PDF
31-12-2015 full format 30-08-2016 2016-56100002 PDF
31-12-2014 full format 10-08-2015 2015-41400164 PDF
31-12-2013 full format 23-07-2014 2014-34000555 PDF
31-12-2012 full format 24-07-2013 2013-34900061 PDF
31-12-2011 full format 13-08-2012 2012-40500259 PDF
31-12-2010 full format 29-07-2011 2011-36500448 PDF
31-12-2009 full format 30-08-2010 2010-49900551 PDF
31-12-2008 full format 25-08-2009 2009-64000096 PDF
31-12-2007 full format 31-07-2008 2008-52400278 PDF

Key figures and ratios

per financial year, computed from the annual accounts
Line Trend2025202420232022202120202019201820172016201520142013201220112010200920082007
---------54,45382,42627,03742,95545,521-34,98250,79022,41720,125
---------36,02354,05416,79528,37930,535-27,13336,57418,38013,239
----------1,84200018,622-0037,701-
101,545-113,49465248,872-8,156104,106-34,25216,76828,036-23,018-20,250-42,64520,43369,333-51,87418,78048,107-27,630-
153,486127,266104,885154,729142,874149,178140,740137,226104,77387,27171,90617,8521,057-2,32317,71528,02159,11130,40522,089
-----------25.8%41.5%51.1%0.3%29.6%48.6%--
53.5%48.4%36.1%52.8%58.1%53.4%83.3%80.9%68.1%70.5%57.5%22.4%6.2%9.6%20.5%15.3%55.0%39.5%75.7%
2.151.941.562.122.382.155.975.223.143.392.291.201.010.981.331.353.613.024.12
1.941.701.421.932.021.814.433.881.931.681.401.120.730.951.041.083.010.924.12
0.871.061.770.890.720.870.200.240.470.420.743.4715.029.383.895.560.821.530.32
69.9%78.9%91.7%78.8%51.6%68.7%20.3%40.0%38.2%39.1%66.5%51.7%201.6%213.2%-11.6%88.4%46.2%20.8%54.7%
37.4%38.2%33.1%41.6%29.9%36.7%16.9%32.4%26.0%27.6%38.3%11.6%12.6%20.5%-2.4%13.5%25.5%8.2%41.5%
-----------101 days96 days97 days131 days85 days90 days--
-----------256 days637 days242 days4 days18 days18 days--

A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.

Insights on Pharm'up development

The operating result for 2025 is 18% higher than in 2024 and the highest since 2022. It is the second rise in a row, after the fall in 2023.

Debt's share of the balance-sheet total falls from 51.6% to 46.5%. Equity is higher and debt is lower.

Next steps